Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study

被引:5
|
作者
Marateb, Hamid Reza [1 ,2 ]
von Cube, Maja [3 ,4 ]
Sami, Ramin [5 ]
Haghjooy Javanmard, Shaghayegh [6 ]
Mansourian, Marjan [2 ,7 ]
Amra, Babak [8 ]
Soltaninejad, Forogh [9 ]
Mortazavi, Mojgan [10 ]
Adibi, Peyman [11 ]
Khademi, Nilufar [12 ]
Sadat Hosseini, Nastaran [12 ]
Toghyani, Arash [12 ]
Hassannejad, Razieh [13 ]
Mananas, Miquel Angel [2 ,14 ]
Binder, Harald [3 ,4 ]
Wolkewitz, Martin [3 ,4 ]
机构
[1] Univ Isfahan, Engn Fac, Biomed Engn Dept, Esfahan, Iran
[2] Univ Politecn Catalunya Barcelona Tech UPC, Automat Control Dept ESAII, Biomed Engn Res Ctr CREB, Bldg H,Floor 4,Av Diagonal 647, Barcelona 08028, Spain
[3] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany
[4] Univ Freiburg, Med Ctr, Freiburg, Germany
[5] Isfahan Univ Med Sci, Sch Med, Dept Internal Med, Esfahan, Iran
[6] Isfahan Univ Med Sci, Cardiovasc Res Inst, Appl Physiol Res Ctr, Esfahan, Iran
[7] Isfahan Univ Med Sci, Sch Hlth, Dept Epidemiol & Biostat, Esfahan, Iran
[8] Isfahan Univ Med Sci, Bamdad Resp Res Ctr, Esfahan, Iran
[9] Isfahan Univ Med Sci, Sch Med, Resp Res Ctr, Dept Internal Med,Pulm Div, Esfahan, Iran
[10] Isfahan Univ Med Sci, Isfahan Kidney Dis Res Ctr, Esfahan, Iran
[11] Isfahan Univ Med Sci, Isfahan Gastroenterol & Hepatol Res Ctr IGHRC, Esfahan, Iran
[12] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[13] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Cardiovasc Res Inst, Esfahan, Iran
[14] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Madrid, Spain
基金
欧盟地平线“2020”;
关键词
Cause-specific hazard regression; COVID-19; Mortality; Prognosis; Risk assessment; Risk chart; COX REGRESSION-ANALYSIS; CARDIOVASCULAR-DISEASE; CUMULATIVE INCIDENCE; HYPERTENSION; INSIGHTS; HAZARDS; CURVES; AREAS; SCORE; ROC;
D O I
10.1186/s12874-021-01340-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. Methods We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission: sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead. Results Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC = 0.872 [CI 95%: 0.835-0.910]). Conclusions This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
    Hamid Reza Marateb
    Maja von Cube
    Ramin Sami
    Shaghayegh Haghjooy Javanmard
    Marjan Mansourian
    Babak Amra
    Forogh Soltaninejad
    Mojgan Mortazavi
    Peyman Adibi
    Nilufar Khademi
    Nastaran Sadat Hosseini
    Arash Toghyani
    Razieh Hassannejad
    Miquel Angel Mañanas
    Harald Binder
    Martin Wolkewitz
    BMC Medical Research Methodology, 21
  • [2] A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study
    Sami, Ramin
    Soltaninejad, Forogh
    Amra, Babak
    Naderi, Zohre
    Haghjooy Javanmard, Shaghayegh
    Iraj, Bijan
    Haji Ahmadi, Somayeh
    Shayganfar, Azin
    Dehghan, Mehrnegar
    Khademi, Nilufar
    Sadat Hosseini, Nastaran
    Mortazavi, Mojgan
    Mansourian, Marjan
    Mananas, Miquel Angel
    Marateb, Hamid Reza
    Adibi, Peyman
    PLOS ONE, 2020, 15 (11):
  • [3] Mortality risk in a Romanian cohort of patients hospitalised for COVID-19
    Frent, Stefan-Marian
    Bikov, Andras
    Bobu, Emanuel
    Pleava, Roxana
    Serban, Costela
    Marincu, Iosif
    Marc, Monica
    Mihaicuta, Stefan
    Oancea, Cristian
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [4] Probabilistic Risk Assessment of COVID-19 Patients at COVID-19 Assessment Centre
    Ting, Choo-Yee
    Zakariah, Helmi
    Yusri, Yasmin Zulaikha Mohd
    INTERNATIONAL JOURNAL OF TECHNOLOGY, 2022, 13 (06) : 1193 - 1201
  • [5] Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study
    Madian, Ali
    Eliwa, Ahmed
    Abdalla, Hytham
    Aly, Haitham A. Azeem
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (08) : 939 - 948
  • [6] Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study
    Ali Madian
    Ahmed Eliwa
    Hytham Abdalla
    Haitham A Azeem Aly
    World Journal of Hepatology, 2021, (08) : 939 - 948
  • [7] Clinical Characteristics and Risk Factors for Mortality in COVID-19 Patients: A Retrospective Cohort Study
    Khajoei, Rahimeh
    Heydarpour, Nabiollah
    Sadeghi, Reza
    Balvardi, Mohadeseh
    Jafari, Hamid
    Shokohian, Sajad
    Rahmani, Farzad
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (05) : LC9 - LC14
  • [8] Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
    Choi, Jae Chol
    Jung, Sun-Young
    Yoon, Una A.
    You, Seung-Hun
    Kim, Myo-Song
    Baek, Moon Seong
    Jung, Jae-Woo
    Kim, Won-Young
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 13
  • [9] COVID-19: Risk factors for increased mortality in younger COVID-19 patients
    不详
    ERNAHRUNGS UMSCHAU, 2022, 69 (06): : M297 - M297
  • [10] The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
    Wu, Jashin J.
    Liu, Jeffrey
    Thatiparthi, Akshitha
    Martin, Amylee
    Egeberg, Alexander
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1395 - 1398